Acute leukemia in the time of COVID-19

Affiliations

¹ Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland. Electronic address: mathilde.gavillet@chuv.ch.
² Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Mathilde Gavillet et al. Leuk Res. 2020 May.

. 2020 May:92:106353.

doi: 10.1016/j.leukres.2020.106353. Epub 2020 Mar 26.

¹ Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland. Electronic address: mathilde.gavillet@chuv.ch.
² Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

No abstract available

Conflict of interest statement

Declaration of Competing Interest The study authors have no conflicts of interest to disclose.

1. Liang W., Guan W., Chen R. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020:335–337. - PMC - PubMed
1. D’Antiga L. Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl. 2020 - PubMed
1. Burke P.J., Braine H.G., Rathbun H.K., Owens A.H., Jr. The clinical significance and management of fever in acute myelocytic leukemia. Johns Hopkins Med. J. 1976:1–12. - PubMed
1. Dohner H., Estey E., Grimwade D. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017:424–447. - PMC - PubMed
1. Greenberg P.L., Tuechler H., Schanz J. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012:2454–2465. - PMC - PubMed